NCT01779492View on ClinicalTrials.gov

A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

GL2907

once a day

DRUG

Oxycontine CR 10mg

twice a day

Trial Locations (1)

Unknown

AJOU University Hospital, Suwon

Sponsors
All Listed Sponsors
lead

GL Pharm Tech Corporation

INDUSTRY

NCT01779492 - A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter